Published in J Gastroenterol on April 09, 2010
APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest (2011) 1.23
Sequential expression of putative stem cell markers in gastric carcinogenesis. Br J Cancer (2011) 1.22
Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol (2010) 1.14
CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem (2011) 1.08
Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review. PLoS One (2013) 1.04
CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer (2011) 1.02
High expression of cancer stem cell markers in cholangiolocellular carcinoma. Surg Today (2012) 0.93
Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer (2013) 0.92
The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review). Int J Oncol (2014) 0.88
CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality? Curr Colorectal Cancer Rep (2011) 0.88
Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today (2011) 0.86
Strong expression of CD133 is associated with increased cholangiocarcinoma progression. World J Gastroenterol (2011) 0.83
Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma. Int J Clin Exp Pathol (2015) 0.82
Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expressions in gallbladder carcinoma. Surg Today (2012) 0.80
Downregulated expression of PHLDA1 protein is associated with a malignant phenotype of cholangiocarcinoma. Oncol Lett (2015) 0.76
Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma. Int J Mol Sci (2017) 0.75
Identification of human brain tumour initiating cells. Nature (2004) 38.87
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 14.87
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer (2007) 3.65
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene (2009) 2.86
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res (2008) 2.52
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology (2008) 2.40
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res (2007) 2.34
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer (2008) 1.93
Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res (2006) 1.89
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer (2008) 1.75
Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol (2006) 1.65
Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract (2008) 1.62
Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. ScientificWorldJournal (2008) 1.40
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res (2009) 1.36
Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas (2008) 1.33
Report of the 16th follow-up survey of primary liver cancer. Hepatol Res (2005) 1.25
Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.20
Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma. Br J Surg (2010) 1.15
Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. Int J Oncol (2009) 0.99
Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report. J Med Invest (2008) 0.91
Expression of hypoxia-inducible factor-1 alpha (HIF-1alpha) in patients with the gallbladder carcinoma. Int J Clin Oncol (2010) 0.83
Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. J Gastroenterol (2008) 0.82
Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. J Gastroenterol (2006) 0.75
Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells (2005) 3.66
Prognosis of aortic intramural hematoma with and without penetrating atherosclerotic ulcer: a clinical and radiological analysis. Circulation (2002) 3.40
Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys (2003) 2.34
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.81
Strategies for improving the outcomes of small-for-size grafts in adult-to-adult living-donor liver transplantation. J Hepatobiliary Pancreat Surg (2008) 1.64
Curved nitinol stent-graft placement for treating blunt thoracic aortic injury: an early experience. Ann Thorac Surg (2008) 1.47
The changes of the medial right lobe, transplanted with left lobe liver graft from living donors. Transplantation (2009) 1.42
A new technique to acquire additional liver volume for left lobe graft in living donor liver transplantation. Hepatogastroenterology (2008) 1.42
Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation. Pancreas (2008) 1.33
Cancer stem cells in human gastrointestinal cancers. Hum Cell (2006) 1.30
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res (2003) 1.21
Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients. Ann Surg Oncol (2006) 1.20
Large human islets secrete less insulin per islet equivalent than smaller islets in vitro. Islets (2011) 1.20
MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway. Oncogene (2003) 1.19
Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α. Cell Transplant (2011) 1.18
Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol (2012) 1.18
Rapid-growing solitary necrotic nodule of the liver. J Med Invest (2006) 1.15
Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery (2002) 1.14
Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J Gastroenterol (2009) 1.10
Secondary aortoesophageal fistula after thoracic endovascular aortic repair for a huge aneurysm. Diagn Interv Radiol (2012) 1.10
A practical synthesis of (S)-2-cyclohexyl-2-phenylglycolic acid via organocatalytic asymmetric construction of a tetrasubstituted carbon center. Org Lett (2005) 1.08
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res (2005) 1.07
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res (2005) 1.06
Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas (2006) 1.05
Reading aloud and arithmetic calculation improve frontal function of people with dementia. J Gerontol A Biol Sci Med Sci (2005) 1.04
Significance of skp2 expression in primary breast cancer. Clin Cancer Res (2006) 1.02
Radiologic variations in gastrorenal shunts and collateral veins from gastric varices in images obtained before balloon-occluded retrograde transvenous obliteration. Cardiovasc Intervent Radiol (2007) 1.02
Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01
Evaluation of reconstruction after proximal gastrectomy: prospective comparative study of jejunal interposition and jejunal pouch interposition. Hepatogastroenterology (2006) 1.00
Somatic mutations of epidermal growth factor receptor in colorectal carcinoma. Clin Cancer Res (2005) 1.00
Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00
Evaluation of osmolality of density gradient for human islet purification. Cell Transplant (2012) 0.99
Significance of sonic hedgehog signaling after massive hepatectomy in a rat. Surg Today (2012) 0.98
Human adipose-derived stem cells: potential clinical applications in surgery. Surg Today (2010) 0.98
Therapeutic effectiveness of diagnostic lymphangiography for refractory postoperative chylothorax and chylous ascites: correlation with radiologic findings and preceding medical treatment. AJR Am J Roentgenol (2013) 0.98
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol (2005) 0.98
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 0.98
N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma. Clin Cancer Res (2004) 0.97
"Downgrading" of gastric varices with multiple collateral veins in balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol (2005) 0.97
Long-term results of endovascular stent graft placement of ureteroarterial fistula. Cardiovasc Intervent Radiol (2012) 0.97
Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg (2015) 0.97
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001). Int J Clin Oncol (2014) 0.96
Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol (2014) 0.95
Real time elastography for noninvasive diagnosis of liver fibrosis. J Hepatobiliary Pancreat Surg (2009) 0.95
Variables associated with islet yield in autologous islet cell transplantation for chronic pancreatitis. Proc (Bayl Univ Med Cent) (2010) 0.94
Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol (2006) 0.94
Influence of Dai-kenchu-to (DKT) on human portal blood flow. Hepatogastroenterology (2008) 0.94
Hepatic screlosed hemangioma which was misdiagnosed as metastasis of gastric cancer: report of a case. J Med Invest (2012) 0.94
Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2014) 0.93
Characterization of human pancreatic progenitor cells. Cell Transplant (2010) 0.93
Impact of splenectomy in patients with liver cirrhosis: Results from 18 patients in a single center experience. Hepatol Res (2010) 0.93
Renal arteriovenous fistula with rapid blood flow successfully treated by transcatheter arterial embolization: application of interlocking detachable coil as coil anchor. Cardiovasc Intervent Radiol (2004) 0.93
Oxaliplatin-related sinusoidal obstruction syndrome mimicking metastatic liver tumors. Hepatol Res (2013) 0.93
High expression of cancer stem cell markers in cholangiolocellular carcinoma. Surg Today (2012) 0.93
Comparison of ulinastatin, gabexate mesilate, and nafamostat mesilate in preservation solution for islet isolation. Cell Transplant (2012) 0.92
Clinical significance of the expression of activin A in esophageal carcinoma. Int J Oncol (2003) 0.92
Ductal injection of JNK inhibitors before pancreas preservation prevents islet apoptosis and improves islet graft function. Hum Gene Ther (2009) 0.92
Hepatocellular carcinoma with spontaneous regression: report of the rare case. Hepatogastroenterology (2008) 0.92
Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report. J Med Invest (2008) 0.91
Hybrid management of ruptured isolated superior mesenteric artery dissecting aneurysm. J Vasc Surg (2011) 0.91